Dual orexin receptor antagonist (unnamed in document)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual orexin receptor antagonist (unnamed in document), covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia. [Phase 2]